New York, United States
Scientia Ventures™ invests in early to mid-stage technology companies that target computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. Our strength is working with entrepreneurs and big ideas to build companies with the potential to transform healthcare. Our Partners have a long history of working together, many of whom are former founders, operators or CEO’s of important healthcare companies and who have domain expertise across healthcare, finance and intellectual property.
8
Total Investments
7
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About Scientia Ventures
Recent Investments (8)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Sep 2021 | |
| Seed Round | •••••• | Aug 2021 | |
| Seed Round | •••••• | Mar 2020 | |
| Series A - X | •••••• | Jul 2019 | |
| Seed Round | •••••• | Jan 2019 | |
•••• ••••
|
Seed Round | •••••• | Nov 2017 |
|
•••• ••••
|
Seed Round | •••••• | Jan 2014 |
|
•••• ••••
|
Seed Round | •••••• | Jan 2014 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
